2024/10/01 by Natasha L. Tilston‐Lunel · 1 voice · 1 citation
Medicine · Agricultural and Biological Sciences · #Viral Infections and Vectors #Vector-Borne Animal Diseases #Mosquito-borne diseases and control
paper · doi:10.1099/jgv.0.002027
openalex publication_date 2024/10/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/22
On 2 February 2024, the Pan American Health Organization/World Health Organization issued an epidemiological alert on rising Oropouche virus (OROV) infections in South America. By 3 August 2024, this alert level had escalated from medium to high. OROV has been a public health concern in Central and South America since its emergence in Brazil in the 1960s. However, the 2024 outbreak marks a turning point, with the sustained transmission in non-endemic regions of Brazil, local transmission in Cuba, two fatalities and several cases of vertical transmission. As of the end of August 2024, 9852 OROV cases have been confirmed. The 2024 OROV outbreak underscores critical gaps in our understanding of OROV pathogenesis and highlights the urgent need for antivirals and vaccines. This review aims to provide a concise overview of OROV, a neglected orthobunyavirus.